Global Zika Virus Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 203532
  • calendar_today Published On: Sep, 2019
  • file_copy Pages: 119
  • list Machinery & Equipment

Scope of the Report:

The worldwide market for Zika Virus Vaccines is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new study.

This report focuses on the Zika Virus Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

NHI

Sanofi

GSK

Bharat.

Takeda

Inovio Pharmaceuticals

GeneOne Life Science Inc

PaxVax

Gilead Sciences Inc.

Intrexon Corp.

NewLink Genetics Corp

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

DNA Vaccine

Inactivated Vaccine

Purified Inactivated Vaccine

Table of Contents

Market Segment by Applications, can be divided into

Hospitals

Clinics

Academic and Research

Others

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Zika Virus Vaccines product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Zika Virus Vaccines, with price, sales, revenue and global market share of Zika Virus Vaccines in 2017 and 2018.

Chapter 3, the Zika Virus Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Zika Virus Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Zika Virus Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Zika Virus Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Zika Virus Vaccines Introduction

1.2 Market Analysis by Type

1.2.1 DNA Vaccine

1.2.2 Inactivated Vaccine

1.2.3 Purified Inactivated Vaccine

1.2.4 Table of Contents

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Clinics

1.3.3 Academic and Research

1.3.4 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 NHI

2.1.1 Business Overview

2.1.2 Zika Virus Vaccines Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 NHI Zika Virus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Sanofi

2.2.1 Business Overview

2.2.2 Zika Virus Vaccines Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sanofi Zika Virus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 GSK

2.3.1 Business Overview

2.3.2 Zika Virus Vaccines Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GSK Zika Virus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Bharat.

2.4.1 Business Overview

2.4.2 Zika Virus Vaccines Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Bharat. Zika Virus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Takeda

2.5.1 Business Overview

2.5.2 Zika Virus Vaccines Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Takeda Zika Virus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Inovio Pharmaceuticals

2.6.1 Business Overview

2.6.2 Zika Virus Vaccines Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Inovio Pharmaceuticals Zika Virus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 GeneOne Life Science Inc

2.7.1 Business Overview

2.7.2 Zika Virus Vaccines Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 GeneOne Life Science Inc Zika Virus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 PaxVax

2.8.1 Business Overview

2.8.2 Zika Virus Vaccines Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 PaxVax Zika Virus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Gilead Sciences Inc.

2.9.1 Business Overview

2.9.2 Zika Virus Vaccines Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Gilead Sciences Inc. Zika Virus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 Intrexon Corp.

2.10.1 Business Overview

2.10.2 Zika Virus Vaccines Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Intrexon Corp. Zika Virus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.11 NewLink Genetics Corp

2.11.1 Business Overview

2.11.2 Zika Virus Vaccines Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 NewLink Genetics Corp Zika Virus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Zika Virus Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Zika Virus Vaccines Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Zika Virus Vaccines Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Zika Virus Vaccines Manufacturer Market Share in 2018

3.3.2 Top 6 Zika Virus Vaccines Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Zika Virus Vaccines Market Analysis by Regions

4.1 Global Zika Virus Vaccines Sales, Revenue and Market Share by Regions

4.1.1 Global Zika Virus Vaccines Sales and Market Share by Regions (2014-2019)

4.1.2 Global Zika Virus Vaccines Revenue and Market Share by Regions (2014-2019)

4.2 North America Zika Virus Vaccines Sales and Growth Rate (2014-2019)

4.3 Europe Zika Virus Vaccines Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Zika Virus Vaccines Sales and Growth Rate (2014-2019)

4.5 South America Zika Virus Vaccines Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Zika Virus Vaccines Sales and Growth Rate (2014-2019)

5 North America Zika Virus Vaccines by Country

5.1 North America Zika Virus Vaccines Sales, Revenue and Market Share by Country

5.1.1 North America Zika Virus Vaccines Sales and Market Share by Country (2014-2019)

5.1.2 North America Zika Virus Vaccines Revenue and Market Share by Country (2014-2019)

5.2 United States Zika Virus Vaccines Sales and Growth Rate (2014-2019)

5.3 Canada Zika Virus Vaccines Sales and Growth Rate (2014-2019)

5.4 Mexico Zika Virus Vaccines Sales and Growth Rate (2014-2019)

6 Europe Zika Virus Vaccines by Country

6.1 Europe Zika Virus Vaccines Sales, Revenue and Market Share by Country

6.1.1 Europe Zika Virus Vaccines Sales and Market Share by Country (2014-2019)

6.1.2 Europe Zika Virus Vaccines Revenue and Market Share by Country (2014-2019)

6.2 Germany Zika Virus Vaccines Sales and Growth Rate (2014-2019)

6.3 UK Zika Virus Vaccines Sales and Growth Rate (2014-2019)

6.4 France Zika Virus Vaccines Sales and Growth Rate (2014-2019)

6.5 Russia Zika Virus Vaccines Sales and Growth Rate (2014-2019)

6.6 Italy Zika Virus Vaccines Sales and Growth Rate (2014-2019)

7 Asia-Pacific Zika Virus Vaccines by Country

7.1 Asia-Pacific Zika Virus Vaccines Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Zika Virus Vaccines Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Zika Virus Vaccines Revenue and Market Share by Country (2014-2019)

7.2 China Zika Virus Vaccines Sales and Growth Rate (2014-2019)

7.3 Japan Zika Virus Vaccines Sales and Growth Rate (2014-2019)

7.4 Korea Zika Virus Vaccines Sales and Growth Rate (2014-2019)

7.5 India Zika Virus Vaccines Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Zika Virus Vaccines Sales and Growth Rate (2014-2019)

8 South America Zika Virus Vaccines by Country

8.1 South America Zika Virus Vaccines Sales, Revenue and Market Share by Country

8.1.1 South America Zika Virus Vaccines Sales and Market Share by Country (2014-2019)

8.1.2 South America Zika Virus Vaccines Revenue and Market Share by Country (2014-2019)

8.2 Brazil Zika Virus Vaccines Sales and Growth Rate (2014-2019)

8.3 Argentina Zika Virus Vaccines Sales and Growth Rate (2014-2019)

8.4 Colombia Zika Virus Vaccines Sales and Growth Rate (2014-2019)

9 Middle East and Africa Zika Virus Vaccines by Countries

9.1 Middle East and Africa Zika Virus Vaccines Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Zika Virus Vaccines Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Zika Virus Vaccines Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Zika Virus Vaccines Sales and Growth Rate (2014-2019)

9.3 Turkey Zika Virus Vaccines Sales and Growth Rate (2014-2019)

9.4 Egypt Zika Virus Vaccines Sales and Growth Rate (2014-2019)

9.5 Nigeria Zika Virus Vaccines Sales and Growth Rate (2014-2019)

9.6 South Africa Zika Virus Vaccines Sales and Growth Rate (2014-2019)

10 Global Zika Virus Vaccines Market Segment by Type

10.1 Global Zika Virus Vaccines Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Zika Virus Vaccines Sales and Market Share by Type (2014-2019)

10.1.2 Global Zika Virus Vaccines Revenue and Market Share by Type (2014-2019)

10.2 DNA Vaccine Sales Growth and Price

10.2.1 Global DNA Vaccine Sales Growth (2014-2019)

10.2.2 Global DNA Vaccine Price (2014-2019)

10.3 Inactivated Vaccine Sales Growth and Price

10.3.1 Global Inactivated Vaccine Sales Growth (2014-2019)

10.3.2 Global Inactivated Vaccine Price (2014-2019)

10.4 Purified Inactivated Vaccine Sales Growth and Price

10.4.1 Global Purified Inactivated Vaccine Sales Growth (2014-2019)

10.4.2 Global Purified Inactivated Vaccine Price (2014-2019)

10.5 Table of Contents Sales Growth and Price

10.5.1 Global Table of Contents Sales Growth (2014-2019)

10.5.2 Global Table of Contents Price (2014-2019)

11 Global Zika Virus Vaccines Market Segment by Application

11.1 Global Zika Virus Vaccines Sales Market Share by Application (2014-2019)

11.2 Hospitals Sales Growth (2014-2019)

11.3 Clinics Sales Growth (2014-2019)

11.4 Academic and Research Sales Growth (2014-2019)

11.5 Others Sales Growth (2014-2019)

12 Zika Virus Vaccines Market Forecast (2019-2024)

12.1 Global Zika Virus Vaccines Sales, Revenue and Growth Rate (2019-2024)

12.2 Zika Virus Vaccines Market Forecast by Regions (2019-2024)

12.2.1 North America Zika Virus Vaccines Market Forecast (2019-2024)

12.2.2 Europe Zika Virus Vaccines Market Forecast (2019-2024)

12.2.3 Asia-Pacific Zika Virus Vaccines Market Forecast (2019-2024)

12.2.4 South America Zika Virus Vaccines Market Forecast (2019-2024)

12.2.5 Middle East and Africa Zika Virus Vaccines Market Forecast (2019-2024)

12.3 Zika Virus Vaccines Market Forecast by Type (2019-2024)

12.3.1 Global Zika Virus Vaccines Sales Forecast by Type (2019-2024)

12.3.2 Global Zika Virus Vaccines Market Share Forecast by Type (2019-2024)

12.4 Zika Virus Vaccines Market Forecast by Application (2019-2024)

12.4.1 Global Zika Virus Vaccines Sales Forecast by Application (2019-2024)

12.4.2 Global Zika Virus Vaccines Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Zika Virus Vaccines Picture

Table Product Specifications of Zika Virus Vaccines

Figure Global Sales Market Share of Zika Virus Vaccines by Types in 2018

Please fill the form below, to recieve the report sample


+1